Virchow Biotech

Virchow Biotech (P) Ltd is a leading global player in the Biopharma sector with over 20 years of operational experience. The company, based in Hyderabad, India, and with offices in the USA, is ISO 13485:2012 and WHO-GMP certified. Employing 1160 individuals, VBPL boasts state-of-the-art clean-room manufacturing facilities and fill-finish lines for various drug products. The company specializes in Research and Development, clinical trials, large-scale production, and commercialization of Plasma Products, Recombinants, Biologicals, and Bio-Pharmaceuticals. With a mission to provide high-quality Biopharma products at an affordable price, VBPL aims to serve economically challenged patients worldwide through biotechnology. The company's portfolio encompasses a wide range of biologicals and bio-generics across therapeutic segments such as Woundcare, Gynaecology, Urology, Oncology, Vaccines, and Probiotics. Virchow Biotech is part of the Virchow Group, which includes other companies specializing in the manufacturing of various APIs. Noteworthy achievements include being the first company to commercialize biogenerics of PDGF, Teriparatide, Pegylated Interferon, and Rasburicase. In addition to manufacturing, VBPL also offers Contract Research and Manufacturing services and engages in co-development of products for diverse markets and customers globally. Overall, VBPL's commitment to innovation and quality positions the company as a key player in the global Biopharma, Biotechnology, and Pharmaceutical industries.